291 related articles for article (PubMed ID: 34888168)
1. Agmatine as a novel candidate for rapid-onset antidepressant response.
Valverde AP; Camargo A; Rodrigues ALS
World J Psychiatry; 2021 Nov; 11(11):981-996. PubMed ID: 34888168
[TBL] [Abstract][Full Text] [Related]
2. Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice.
Neis VB; Bettio LEB; Moretti M; Rosa PB; Ribeiro CM; Freitas AE; Gonçalves FM; Leal RB; Rodrigues ALS
Pharmacol Biochem Behav; 2016; 150-151():108-114. PubMed ID: 27743829
[TBL] [Abstract][Full Text] [Related]
3. Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators.
Camargo A; Rodrigues ALS
Chronic Stress (Thousand Oaks); 2019; 3():2470547019858083. PubMed ID: 32440595
[TBL] [Abstract][Full Text] [Related]
4. Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
Neis VB; Bettio LB; Moretti M; Rosa PB; Olescowicz G; Fraga DB; Gonçalves FM; Freitas AE; Heinrich IA; Lopes MW; Leal RB; Rodrigues ALS
Pharmacol Biochem Behav; 2018 Oct; 173():44-50. PubMed ID: 30125592
[TBL] [Abstract][Full Text] [Related]
5. Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway.
Tavares MK; Dos Reis S; Platt N; Heinrich IA; Wolin IAV; Leal RB; Kaster MP; Rodrigues ALS; Freitas AE
Neurochem Int; 2018 Sep; 118():275-285. PubMed ID: 29763645
[TBL] [Abstract][Full Text] [Related]
6. Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency.
Nikkheslat N
Brain Behav Immun Health; 2021 Dec; 18():100383. PubMed ID: 34849492
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine.
Wohleb ES; Gerhard D; Thomas A; Duman RS
Curr Neuropharmacol; 2017; 15(1):11-20. PubMed ID: 26955968
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.
Browne CA; Lucki I
Front Pharmacol; 2013 Dec; 4():161. PubMed ID: 24409146
[TBL] [Abstract][Full Text] [Related]
9. Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets.
Kouba BR; de Araujo Borba L; Borges de Souza P; Gil-Mohapel J; Rodrigues ALS
Cells; 2024 Feb; 13(5):. PubMed ID: 38474387
[TBL] [Abstract][Full Text] [Related]
10. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto K
Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
[TBL] [Abstract][Full Text] [Related]
11. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
12. Agmatine Reverses Sub-chronic Stress induced Nod-like Receptor Protein 3 (NLRP3) Activation and Cytokine Response in Rats.
Sahin C; Albayrak O; Akdeniz TF; Akbulut Z; Yanikkaya Demirel G; Aricioglu F
Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):367-75. PubMed ID: 27061450
[TBL] [Abstract][Full Text] [Related]
13. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
Pham TH; Gardier AM
Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR.
Nowak W; Grendas LN; Sanmarco LM; Estecho IG; Arena ÁR; Eberhardt N; Rodante DE; Aoki MP; Daray FM; Carrera Silva EA; Errasti AE
EBioMedicine; 2019 Dec; 50():290-305. PubMed ID: 31753725
[TBL] [Abstract][Full Text] [Related]
15. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.
Li YF
Pharmacol Ther; 2020 Apr; 208():107494. PubMed ID: 31991195
[TBL] [Abstract][Full Text] [Related]
16. An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Zhang K; Hashimoto K
Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009
[No Abstract] [Full Text] [Related]
17. Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives.
Shin C; Kim YK
Psychiatry Investig; 2020 Mar; 17(3):181-192. PubMed ID: 32209965
[TBL] [Abstract][Full Text] [Related]
18. Rapid acting antidepressants in the mTOR pathway: Current evidence.
K V A; Mohan AS; Chakravarty S
Brain Res Bull; 2020 Oct; 163():170-177. PubMed ID: 32739296
[TBL] [Abstract][Full Text] [Related]
19. Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice.
Neis VB; Moretti M; Manosso LM; Lopes MW; Leal RB; Rodrigues AL
Pharmacol Biochem Behav; 2015 Mar; 130():9-14. PubMed ID: 25553821
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.
Demchenko I; Tassone VK; Kennedy SH; Dunlop K; Bhat V
Front Psychiatry; 2022; 13():864902. PubMed ID: 35722550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
